Dayal, S., Aluri, J., Hall, N., Filippov, G., Moline, M., Reyderman, L., & Landry, I. (2021). Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant. Pharmacol Res Perspect.
Style de citation ChicagoDayal, Satish, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Margaret Moline, Larisa Reyderman, et Ishani Landry. "Effect of Hepatic Impairment On Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacol Res Perspect 2021.
Style de citation MLADayal, Satish, et al. "Effect of Hepatic Impairment On Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacol Res Perspect 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.